- Qiagen clc genomics workbench mac os#
- Qiagen clc genomics workbench update#
- Qiagen clc genomics workbench free#
With QIAGEN CLC LightSpeed technology, labs can run WGS analyses for about $1 per genome and WES for less than a few cents per exome using cloud infrastructure. It can analyze an entire human genome at 34x coverage on an ordinary computer in just 25 minutes and a 50x whole exome in 90 seconds within standard cloud environments.
Qiagen clc genomics workbench update#
The update to QIAGEN CLC Genomics Workbench Premium incorporates LightSpeed technology, a software accelerator that, at unprecedented speed, converts raw sequencing data in FASTQ files from any paired-end short read sequencing platform into interpretable lists of genetic variants in the VCF format. QIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN, today announced their enhanced QIAGEN CLC Genomics Workbench Premium that removes the data-analysis bottleneck of next-generation sequencing (NGS) by adding game-changing analysis speed to analyze and interpret whole genome sequencing (WGS), whole exome sequencing (WES) and large panel sequencing data. > Included in market-leading CLC analysis platform for cloud, server or desktop use > Removes key barriers in cost and speed for adopting WES and WGS screening > New innovation set to change speed and cost of whole exome sequencing (WES) and whole genome sequencing (WGS) "Press Release: Qiagen Digital Insights Launches Ultra-fast NGS Analysis Able to Process a Whole Genome in 25 Minutes for a $1 in Cloud Computing Costs". However these products are no longer under development.Product › Details Qiagen CLC LightSpeed technology (software accelerator) Hardware Įarly on, the company initially presented own-developed high-performance computing solutions, focusing on accelerating open source algorithms such as HMMER, Smith-Waterman and ClustalW, using FPGA technology.
Qiagen clc genomics workbench free#
In 2020, CLC bio released a free plug-in that enables workflow execution on AWS directly from the CLC Genomics Workbench desktop software. In 2019, this platform was adapted for and approved for use in AWS GovCloud. In 2017, CLC bio launched their CLC Genomics Cloud Engine as a command-line driven platform for cloud-based bioinformatics workflow execution on Amazon Web Services. Features include read mapping and de novo assembly of high-throughput sequencing data, whole-genome detection of SNPs and structural variations, ChIP-seq, RNA-Seq, small RNA analysis, genome finishing, microbial genomics, structural biology, and functions to analyze, visualize, and compare genomic, transcriptomic, and epigenomic data. pathway analysis, genomics, and other omics). Īs additional capabilities were added to the software platform, it was eventually split into several themed Workbenches and plugins with collections of features relevant to different applications (e.g. In 2010, CLC bio was notable as the first commercial platform for bioinformatics analysis that utilized a graphical user interface for building, managing, and deploying analysis workflows as well as command-line tools, a SOAP and REST API, and later, the ability to run containerized tools. CLC bio developed some of their own open source algorithms, as well as their own SIMD-accelerated implementations of several existing popular applications.
Qiagen clc genomics workbench mac os#
Software ĬLC bio's main activities were in software development for desktop ( Mac OS X, Windows, and Linux), enterprise, and cloud software for analysis of biological data. ĬLC bio was acquired by QIAGEN in 2013 and merged into its bioinformatics research and development division with several other purchased platforms in 2014. By 2012, it had additional offices in Cambridge, Massachusetts, Tokyo, Taipei and Delhi, with staff largely from research backgrounds (30% having a PhD) and had built a userbase of around 250,000 users in both academic institutions and biotechnology companies. Its product's development was also partly funded by collaborating with researchers on grant-funded projects. CLC bio was a bioinformatics software company that developed a software suite subsequently purchased by QIAGEN.ĬLC bio started commercial activities on Januheadquartered in Aarhus, Denmark.
0 kommentar(er)
